Envestnet Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.5M Buy
126,996
+12,339
+11% +$2.55M 0.01% 1184
2025
Q4
$23.7M Sell
114,657
-6,266
-5% -$1.25M 0.01% 1109
2025
Q3
$21.7M Buy
120,923
+438
+0.4% +$74.6K 0.01% 1226
2025
Q2
$19.4M Buy
120,485
+4,945
+4% +$788K 0.01% 1275
2025
Q1
$19.7M Buy
115,540
+1,985
+2% +$345K 0.01% 1204
2024
Q4
$18.9M Buy
113,555
+4,878
+4% +$834K 0.01% 1235
2024
Q3
$18.7M Buy
108,677
+58,585
+117% +$9.7M 0.01% 1223
2024
Q2
$7.71M Sell
50,092
-1,426
-3% -$214K ﹤0.01% 1726
2024
Q1
$7.92M Sell
51,518
-3,162
-6% -$482K ﹤0.01% 1677
2023
Q4
$8.64M Buy
54,680
+13,354
+32% +$1.92M ﹤0.01% 1537
2023
Q3
$6.05M Sell
41,326
-5,122
-11% -$780K ﹤0.01% 1676
2023
Q2
$7.11M Buy
46,448
+3,610
+8% +$563K ﹤0.01% 1499
2023
Q1
$6.64M Sell
42,838
-6,637
-13% -$1.04M ﹤0.01% 1499
2022
Q4
$7.63M Buy
49,475
+2,947
+6% +$435K ﹤0.01% 1346
2022
Q3
$6.14M Buy
46,528
+2,015
+5% +$283K ﹤0.01% 1415
2022
Q2
$6.03M Sell
44,513
-3,034
-6% -$418K ﹤0.01% 1425
2022
Q1
$7.09M Sell
47,547
-1,360
-3% -$201K ﹤0.01% 1408
2021
Q4
$7.92M Sell
48,907
-11,061
-18% -$1.79M ﹤0.01% 1326
2021
Q3
$9.96M Sell
59,968
-30,201
-33% -$5.16M 0.01% 1153
2021
Q2
$15.6M Sell
90,169
-4,257
-5% -$703K 0.01% 901
2021
Q1
$15.2M Sell
94,426
-20,083
-18% -$3.44M 0.01% 834
2020
Q4
$19.2M Sell
114,509
-4,603
-4% -$747K 0.01% 631
2020
Q3
$18.7M Buy
119,112
+6,255
+6% +$1.02M 0.02% 575
2020
Q2
$18.9M Buy
112,857
+16,180
+17% +$2.54M 0.02% 543
2020
Q1
$12.7M Buy
96,677
+17,901
+23% +$2.55M 0.02% 596
2019
Q4
$11.7M Buy
78,776
+831
+1% +$114K 0.01% 738
2019
Q3
$9.65M Buy
77,945
+1,445
+2% +$192K 0.01% 764
2019
Q2
$10.8M Buy
76,500
+23,172
+43% +$3.2M 0.01% 696
2019
Q1
$8.04M Buy
53,328
+8,595
+19% +$1.24M 0.01% 782
2018
Q4
$5.56M Buy
44,733
+33,780
+308% +$4.62M 0.01% 837
2018
Q3
$1.74M Sell
10,953
-10,983
-50% -$1.66M ﹤0.01% 632
2018
Q2
$3.07M Buy
21,936
+1,774
+9% +$244K 0.01% 652
2018
Q1
$2.66M Buy
20,162
+260
+1% +$35.5K 0.01% 608
2017
Q4
$2.48M Buy
19,902
+230
+1% +$28.4K 0.01% 857
2017
Q3
$2.44M Sell
19,672
-295
-1% -$34.9K 0.01% 817
2017
Q2
$2.28M Sell
19,967
-4,467
-18% -$480K 0.01% 873
2017
Q1
$2.57M Sell
24,434
-63
-0.3% -$6.31K 0.01% 829
2016
Q4
$2.23M Buy
24,497
+13,999
+133% +$1.31M 0.01% 871
2016
Q3
$1.05M Sell
10,498
-13,402
-56% -$1.31M ﹤0.01% 1230
2016
Q2
$2.14M Buy
23,900
+104
+0.4% +$9.55K 0.01% 993
2016
Q1
$2.08M Sell
23,796
-18,287
-43% -$1.61M 0.01% 969
2015
Q4
$4.76M Buy
42,083
+3,150
+8% +$339K 0.02% 593
2015
Q3
$3.94M Buy
38,933
+2,780
+8% +$331K 0.02% 655
2015
Q2
$4.48M Sell
36,153
-5,234
-13% -$632K 0.02% 641
2015
Q1
$4.89M Buy
41,387
+36,316
+716% +$4.11M 0.03% 573
2014
Q4
$517K Buy
5,071
+4,883
+2,597% +$477K 0.01% 705
2014
Q3
$17K Sell
188
-829
-82% -$71.9K ﹤0.01% 1941
2014
Q2
$84K Buy
+1,017
New +$77.7K ﹤0.01% 1277
2013
Q3
Sell
-185
Closed -$11K 2425
2013
Q2
$11K Buy
+185
New +$10.6K ﹤0.01% 1625

Other funds holding FBT

Envestnet Asset Management's FBT Position: Q1 2026 in Review

Envestnet Asset Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 11% in Q1 2026, buying an estimated $2.55M and bringing the position to 126,996 shares worth $25.5M. The position accounts for 0.01% of the portfolio, ranked #1184.

Envestnet Asset Management first reported a position in FBT in Q2 2013 and has held it in 49 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Envestnet Asset Management held 126,996 shares of First Trust NYSE Arca Biotechnology Index Fund worth $25.5M as of Q1 2026.
  • Envestnet Asset Management bought 12,339 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.55M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #1184 holding.
  • Envestnet Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 49 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.